CAR T-Cell Immunotherapy Treating T-ALL: Challenges and Opportunities

T-cell acute lymphoblastic leukemia (T-ALL), a form of T-cell malignancy, is a typically aggressive hematological malignancy with high rates of disease relapse and a poor prognosis. Current guidelines do not recommend any specific treatments for these patients, and only allogeneic stem cell transpla...

Descripción completa

Detalles Bibliográficos
Autores principales: Ren, Anqi, Tong, Xiqin, Xu, Na, Zhang, Tongcun, Zhou, Fuling, Zhu, Haichuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9861718/
https://www.ncbi.nlm.nih.gov/pubmed/36680011
http://dx.doi.org/10.3390/vaccines11010165

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9861718/
https://www.ncbi.nlm.nih.gov/pubmed/36680011
http://dx.doi.org/10.3390/vaccines11010165

Ejemplares similares